Supreme Court of the United States
Danco Laboratories, LLC v. Louisiana
May 14, 2026
Summary
In a dissent, Justices Thomas and Alito argue that the manufacturers of mifepristone have failed to demonstrate the irreparable injury required for a stay of the Fifth Circuit's order, and that granting a stay would protect unlawful conduct. They contend that the public interest and criminal nature of the activity outweigh any claimed loss of profit.